T1	Participants 178 224	patients with locally advanced noninflammatory
T2	Participants 225 238	breast cancer
T3	Participants 277 301	Phase III clinical trial
T4	Participants 441 464	locally advanced breast
T5	Participants 536 625	Between 1985 and 1989, 200 patients with clinical Stage III noninflammatory breast cancer
#1	AnnotatorNotes T5	Age and number of patients
T6	Participants 716 847	Of the 179 patients treated with mastectomy after neoadjuvant chemotherapy, 108 participated in a randomized component of the trial
T7	Participants 1149 1190	The median follow-up period was 15 years.
#2	AnnotatorNotes T7	Relates to age of patient
